UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$3.78B |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$718M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$218M |
| 4 |
Union Pacific
UNP
|
+$210M |
| 5 |
Alcon
ALC
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$820M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$604M |
| 3 |
Apple
AAPL
|
+$598M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$524M |
| 5 |
TSMC
TSM
|
+$324M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.29% |
| 2 | Financials | 8.09% |
| 3 | Healthcare | 6.75% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXDX
4326
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $777K | ﹤0.01% |
7,244
-26,610
| -79% | -$3.06M |
|
|
TPH
4327
DELISTED
Tri Pointe Homes
TPH
| $775K | ﹤0.01% |
30,618
+12,165
| +66% | +$276K |
|
4328
IDEAYA Biosciences
IDYA
$3.56B
| $775K | ﹤0.01% |
56,454
-58,149
| -51% | -$969K |
|
4329
Joby Aviation
JOBY
$8.55B
| $774K | ﹤0.01% |
178,409
+28,622
| +19% | +$118K |
|
|
BBT
4330
Beacon Financial Corp
BBT
$2.66B
| $774K | ﹤0.01% |
30,894
+7,610
| +33% | +$217K |
|
4331
CALL
The Joint Corp
JYNT
$119M
| $774K | ﹤0.01% |
46,000
| – | – |
|
4332
Sprinklr
CXM
$1.61B
| $774K | ﹤0.01% |
59,729
-2,949
| -5% | -$29.9K |
|
4333
Arhaus
ARHS
$1.36B
| $772K | ﹤0.01% |
93,168
+28,631
| +44% | +$346K |
|
4334
Global X MSCI Norway ETF
NORW
$88.2M
| $770K | ﹤0.01% |
31,698
-729
| -2% | -$18.3K |
|
4335
Virtus Investment Partners
VRTS
$1.1B
| $770K | ﹤0.01% |
4,044
+457
| +13% | +$92.4K |
|
4336
Select Water Solutions
WTTR
$2.61B
| $770K | ﹤0.01% |
110,605
+2,942
| +3% | +$22.9K |
|
|
MBNE
4337
DELISTED
State Street Nuveen Municipal Bond ESG ETF
MBNE
| $769K | ﹤0.01% |
25,885
+25,316
| +4,449% | +$749K |
|
|
PGP
4338
PIMCO Global StockPLUS & Income Fund
PGP
$100M
| $769K | ﹤0.01% |
103,756
+33
| +0% | +$250 |
|
4339
Adaptive Biotechnologies
ADPT
$3.97B
| $767K | ﹤0.01% |
86,858
+24,722
| +40% | +$218K |
|
4340
Maximus
MMS
$3.1B
| $766K | ﹤0.01% |
9,738
-20,975
| -68% | -$1.62M |
|
4341
First Bancorp
FBNC
$2.68B
| $764K | ﹤0.01% |
21,515
+5,929
| +38% | +$236K |
|
|
PMT
4342
PennyMac Mortgage Investment
PMT
$842M
| $764K | ﹤0.01% |
61,944
+4,483
| +8% | +$60.3K |
|
4343
Grocery Outlet
GO
$980M
| $763K | ﹤0.01% |
26,998
-8,833
| -25% | -$254K |
|
4344
Magnite
MGNI
$3.55B
| $763K | ﹤0.01% |
82,386
+1,654
| +2% | +$17.6K |
|
4345
Fluence Energy
FLNC
$2.44B
| $762K | ﹤0.01% |
37,640
-14,607
| -28% | -$290K |
|
|
MRSN
4346
DELISTED
Mersana Therapeutics
MRSN
| $762K | ﹤0.01% |
7,416
-4,128
| -36% | -$579K |
|
|
CMRC
4347
Commerce.com Inc Series 1
CMRC
$184M
| $759K | ﹤0.01% |
84,881
-21,576
| -20% | -$219K |
|
4348
Nurix Therapeutics
NRIX
$2.65B
| $756K | ﹤0.01% |
85,108
-59,194
| -41% | -$617K |
|
4349
State Street SPDR S&P Global Dividend ETF
WDIV
$281M
| $755K | ﹤0.01% |
12,806
-4,876
| -28% | -$293K |
|
|
CFLT
4350
CALL
DELISTED
Confluent
CFLT
| $753K | ﹤0.01% |
31,300
-26,024
| -45% | -$603K |
|
Similar funds
UBS Group's Q1 2023 Portfolio in Review
As of Q1 2023, UBS Group held 11,664 positions worth $274B, up 2.2% from $268B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group withdrew a net $10.4B in Q1 2023, closing 2,127 positions and reducing 4,260 holdings. Its most notable exit was LHC Group LLC, an estimated $49M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in First Trust Nasdaq Oil & Gas ETF worth $13.3M.
- UBS Group's largest Q1 2023 buy was First Trust Nasdaq Oil & Gas ETF: 493,205 shares worth $13.3M.
- UBS Group added most to UBS Group in Q1 2023, an estimated $3.78B increase.
- UBS Group's biggest Q1 2023 reduction was Microsoft, cutting an estimated $820M.
- UBS Group fully exited LHC Group LLC in Q1 2023, selling an estimated $49M.
- UBS Group's ten largest holdings make up 16% of its $274B portfolio in Q1 2023.
- UBS Group opened 983 new positions and closed 2,127 in Q1 2023.
- UBS Group's portfolio value rose 2.2% quarter-over-quarter to $274B.
Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.